EUVIMEDEUVIMED entdecken
Crossref

Psychopharmacology of patients with multiple sclerosis in Greece during the period 2017-2019

Christos Bakirtzis, Maria-Valeria Karakasi, Marina-Kleopatra Boziki, Theodoros Moysiadis, Dimitra Tsakona, Barbara Fyntanidou, Georgios Papazisis, Eleftherios Thireos, Nikolaos Grigoriadis

Psychiatriki · 2022-02

DOI: 10.22365/jpsych.2022.057 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Psychiatriki, 2022-02. Verfasst von Christos Bakirtzis und 8 weiteren Autor:innen. Beteiligte Einrichtung: Multiple Sclerosis Center, Second Department of Neurology, Aristotle University of Thessaloniki, Thessaloniki, Greece. Hauptthemen laut MEDLINE: Anti-Anxiety Agents, Antipsychotic Agents, Multiple Sclerosis, Psychopharmacology. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Anxiety AgentsAntipsychotic AgentsMultiple SclerosisPsychopharmacologyAntidepressive AgentsBenzodiazepinesGreeceHumans

Stichwörter der Autor:innen

Multiple sclerosisantidepressantsantipsychoticsbenzodiazepinespsychopharmacologypsychostimulants

Substanzen

Anti-Anxiety AgentsAntidepressive AgentsAntipsychotic AgentsBenzodiazepines

Autor:innen und Institutionen

  • Multiple Sclerosis Center, Second Department of Neurology, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Third Department of Psychiatry, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Institute of Applied Biosciences, Center for Research and Technology Hellas, Thessaloniki,Greece.
  • Department of Anesthesiology and ICU, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Department of Clinical Pharmacology, Aristotle University of Thessaloniki, Thessaloniki, Greece.
  • Athens Medical Society, Athens, Greece.

Zitieren

APA

Bakirtzis, C., Karakasi, M. V., Boziki, M. K., Moysiadis, T., Tsakona, D., Fyntanidou, B., Papazisis, G., Thireos, E., & Grigoriadis, N. (2022). Psychopharmacology of patients with multiple sclerosis in Greece during the period 2017-2019. Psychiatriki. https://doi.org/10.22365/jpsych.2022.057

Vancouver

Bakirtzis C, Karakasi MV, Boziki MK, Moysiadis T, Tsakona D, Fyntanidou B, et al. Psychopharmacology of patients with multiple sclerosis in Greece during the period 2017-2019. Psychiatriki. 2022. doi:10.22365/jpsych.2022.057

BibTeX
@article{Bakirtzis2022,
  author = {Bakirtzis, Christos and Karakasi, Maria-Valeria and Boziki, Marina-Kleopatra and Moysiadis, Theodoros and Tsakona, Dimitra and Fyntanidou, Barbara and Papazisis, Georgios and Thireos, Eleftherios and Grigoriadis, Nikolaos},
  title = {Psychopharmacology of patients with multiple sclerosis in Greece during the period 2017-2019},
  journal = {Psychiatriki},
  year = {2022},
  doi = {10.22365/jpsych.2022.057}
}
Kostenlos starten →